Cargando…
Robust Approaches for the Production of Active Ingredient and Drug Product for Human Phage Therapy
To be successful, academic and commercial efforts to reintroduce phage therapy must ensure that only safe and efficacious products are used to treat patients. This raises a number of manufacturing, formulation, and delivery challenges. Since phages are biologics, robust manufacturing processes will...
Autores principales: | Mutti, Michele, Corsini, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791927/ https://www.ncbi.nlm.nih.gov/pubmed/31649636 http://dx.doi.org/10.3389/fmicb.2019.02289 |
Ejemplares similares
-
Phage activity against Staphylococcus aureus is impaired in plasma and synovial fluid
por: Mutti, Michele, et al.
Publicado: (2023) -
Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy
por: Żaczek, Maciej, et al.
Publicado: (2016) -
Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
por: Bretaudeau, Laurent, et al.
Publicado: (2020) -
Tracking the phage trends: A comprehensive review of applications in therapy and food production
por: Jaglan, Anu Bala, et al.
Publicado: (2022) -
Perspectives on Functional Red Mold Rice: Functional Ingredients, Production, and Application
por: Yanli, Feng, et al.
Publicado: (2020)